NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Redmile Group

Redmile Group

San Francisco, Californiaredmilegroup.com

Overview

Redmile Group is a private investment firm founded in 2007 that focuses on investments in the healthcare and life sciences sectors, including biotechnology and medical devices.

Year Founded

2007

AUM

$6.47B

Portfolio Companies

54

Investments

Redmile Group investments
CompanyDateStageLead
Climb Bio, Inc.May 2026Private PlacementCo-investor
Obsidian TherapeuticsApr 2026Private EquityCo-investor
Ambrosia Biosciences Inc.Mar 2026Series BLead
Ambrosia BioMar 2026Series BLead
Impulse DynamicsDec 2025Early FundingCo-investor

Key People

Florian Reinaud

Venture Partner

Gerardo Galvan

Commercial Investment Partner Honorary Director Of Audit And Risk Committee (semi-retired)

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSan Francisco, California
Year Founded2007
AUM$6.47B

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.